Jalen Hurts' blood clot diagnosis sparks joint review by NFL and players' union: report

PHILADELPHIA - The National Football League and its players' union have initiated a joint review into the medical handling of Eagles quarterback Jalen Hurts' blood clot condition. 

What they're saying:

Following the NFLPA's push for an inquiry earlier this week, the two sides released a unified statement on Sunday confirming the active investigation, according to the Associated Press.

The review centers around the timeline of Hurts' diagnosis and subsequent playing time. 

The backstory:

The initial injury occurred when Hurts was struck by a cleat in his calf during an October 4 game against the Los Angeles Rams. 

He reported the discomfort to team medical personnel on October 8, practiced the next day, and flew with the team to London. In the UK, specialists diagnosed him with a superficial vein thrombosis in his left calf, yet the Super Bowl 59 MVP proceeded to play against the Jacksonville Jaguars on October 11.

Hurts has since been placed on injured reserve and is projected to miss the remainder of the season.

Dig deeper:

The Eagles and Hurts' agent, Nicole Lynn, disclosed that the condition escalated to deep vein thrombosis and bilateral pulmonary emboli, indicating the calf clot had traveled to his lungs. 

He is currently prescribed blood thinners and is strictly prohibited from participating in any football activities until his treatment regimen concludes.

The other side:

Despite the union's concerns, NFL Commissioner Roger Goodell has expressed confidence in the team's procedures. 

While welcoming the investigation, Goodell noted that the league's chief medical officer, Dr. Allen Sills, strongly defended the Philadelphia medical staff, asserting that all medical evaluations were thorough and that standard protocols were strictly observed.

Philadelphia EaglesPhiladelphia